Article Information
History
- February 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bart Van Puyvelde1,
- Katleen Van Uytfanghe2,
- Laurence Van Oudenhove3,
- Ralf Gabriels4,5,
- Tessa Van Royen4,6,
- Arne Matthys4,6,
- Morteza Razavi7,
- Richard Yip7,
- Terry Pearson7,
- Marijn van Hulle3,
- Jan Claereboudt3,
- Kevin Wyndham8,
- Don Jones9,10,
- Xavier Saelens4,6,
- Geert A. Martens11,
- Christophe Stove2,
- Dieter Deforce1,
- Lennart Martens4,5,
- Johannes P.C. Vissers8,
- N. Leigh Anderson7 and
- Maarten Dhaenens1,*
- 1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium
- 2Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium
- 3Waters Corporation, 2600 Antwerp, Belgium
- 4VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium
- 5Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium
- 6Department of Biochemistry and Microbiology, Ghent University, 9000 Ghent, Belgium
- 7SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States of America and Victoria, BC Canada
- 8Waters Corporation, Wilmslow SK9 4AX, United Kingdom and Milford, MA 01757, United States of America
- 9Leicester Cancer Research Centre, RKCSB, University of Leicester, UK and John and Lucille van Geest biomarker facility, Cardiovascular Research Centre, Glenfield Hospital, Leicester LE1 7RH, United Kingdom
- 10The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester LE1 7RH, United Kingdom
- 11AZ Delta Medical Laboratories, AZ Delta General Hospital, 8800 Roeselare, Belgium
- ↵*Corresponding author: maarten.dhaenens{at}ugent.be